Giant-cell arteritis associated with myelodysplastic syndrome: French multicenter case control study and literature review.
暂无分享,去创建一个
E. Solary | F. Carrat | O. Decaux | P. Fenaux | L. Adès | F. Maurier | A. Aouba | J. Rossignol | N. Schleinitz | A. Mékinian | O. Fain | M. D’aveni | H. de Boysson | M. Samson | M. Versini | J. Seguier | V. Queyrel | Y. Benhamou | L. Terriou | M. Groh | S. Thietart | A. Roupie | L. Willems | A. Dellal | J. Galland | M. D'Aveni | M. D’Aveni
[1] P. Fenaux,et al. Autoimmune manifestations associated with myelodysplastic syndromes , 2018, Annals of Hematology.
[2] T. Higuchi,et al. Simultaneous Presentation of Giant Cell Arteritis and Myelodysplastic Syndrome in an Elderly Japanese Man , 2018, Internal medicine.
[3] M. McCormack,et al. A Rare Case of Paraneoplastic Aortitis Associated with Chronic Myelomonocytic Leukemia , 2017, Case reports in hematology.
[4] M. Vicaretti,et al. Migratory large vessel vasculitis preceding acute myeloid leukemia: a case report , 2017, Journal of Medical Case Reports.
[5] A. Aouba,et al. Giant-cell arteritis without cranial manifestations , 2016, Medicine.
[6] O. Decaux,et al. Efficacy of Azacitidine in Autoimmune and Inflammatory Disorders associated with Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia Running title : Azacitidine in autoimmune disorders associated with MDS / CMML , 2018 .
[7] J. Piette,et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.
[8] T. Itoh,et al. Acute Myeloid Leukemia Complicated by Giant Cell Arteritis. , 2016, Internal medicine.
[9] K. Imajo,et al. [Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis]. , 2015, [Rinsho ketsueki] The Japanese journal of clinical hematology.
[10] P. Fenaux,et al. Myelodysplastic syndromes , 2014, The Lancet.
[11] H. Yokozaki,et al. Recurrence of abdominal large‐vessel vasculitis and development of severe Sweet syndrome after a single cycle of 5‐azacytidine in a patient with myelodysplastic syndrome , 2014, European journal of haematology.
[12] H. Makino,et al. Large vessel vasculitis with myelodysplastic syndrome. , 2014, Internal medicine.
[13] S. Fleming,et al. Paraneoplastic large vessel arteritis complicating myelodysplastic syndrome , 2012, Leukemia & lymphoma.
[14] Sophie Park,et al. The autoimmune manifestations associated with myelodysplastic syndrome respond to 5‐azacytidine: a report on three cases , 2011, British journal of haematology.
[15] M. Steurer,et al. Large‐vessel arteritis and myelodysplastic syndrome: report of two cases , 2004, European journal of haematology.
[16] T. Sugita,et al. Suppression of fibroblast activity by an inhibitor of dipeptidyl peptidase IV: a possible therapeutic strategy for rheumatoid arthritis. , 2003, Clinical and Experimental Rheumatology.
[17] H. Milionis,et al. Temporal arteritis masquerading as chronic myelomonocytic leukemia. , 2003, Clinical and experimental rheumatology.
[18] G. Espinosa,et al. Myelodysplastic and Myeloproliferative Syndromes Associated with Giant Cell Arteritis and Polymyalgia Rheumatica: A Coincidental Coexistence or a Causal Relationship? , 2002, Clinical Rheumatology.
[19] A. Mega,et al. Aortitis as a manifestation of myelodysplastic syndrome , 2001, Postgraduate medical journal.
[20] B. Johansson,et al. Immune‐mediated complications in patients with myelodysplastic syndromes – clinical and cytogenetic features , 1995, European journal of haematology.
[21] R. Bennett,et al. An association of polymyalgia rheumatica with myelodysplastic syndromes. , 1994, The Journal of rheumatology.
[22] L. Vaillant,et al. [Horton's disease and myelodysplastic syndrome associated with unusual cutaneous manifestations]. , 1992, Annales de dermatologie et de venereologie.